Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy

被引:1
|
作者
Wang, Weiwei [1 ]
Qu, Chaoyi [1 ]
Yan, Huanhuan [1 ]
机构
[1] Xian Peoples Hosp, Shaanxi Eye Hosp, Xian Hosp 4, Xian, Peoples R China
来源
关键词
proliferative diabetic retinopathy; vitrectomy; conbercept; intravitreal; network meta-analysis; PARS-PLANA VITRECTOMY; LINEAR MIXED MODELS; SYSTEMATIC REVIEWS; HEALTH-CARE; INCONSISTENCY; BEVACIZUMAB; PRETREATMENT; RANIBIZUMAB;
D O I
10.3389/fendo.2023.1098165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeIntravitreal Conbercept (IVC) has been shown to be effective in treating proliferative diabetic retinopathy (PDR) as an adjuvant in pars plana vitrectomy (PPV); however, the best timing of IVC injection remains unknown. This network meta-analysis (NMA) sought to ascertain the comparative efficacy of different timings of IVC injection as an adjuvant to PPV on PDR. MethodsA comprehensive literature search was conducted in PubMed, EMBASE, and the Cochrane Library to identify relevant studies published before August 11, 2022. According to the mean time of IVC injection before PPV, the strategy was defined as very long interval if it was > 7 days but <= 9 days, long interval if it was > 5 days but <= 7 days, mid interval if it was > 3 days but <= 5 days, and short interval if it was <= 3 days, respectively. The strategy was defined as perioperative IVC if IVC was injected both before and at the end of PPV, and the strategy was intraoperative IVC if injected immediately at the end of PPV. The mean difference (MD) and odds ratio (OR) with corresponding 95% confidence interval (CI) for continuous and binary variables, respectively, were computed through network meta-analysis using Stata 14.0 MP. ResultsEighteen studies involving 1149 patients were included. There was no statistical difference between intraoperative IVC and control in treating PDR. Except for a very long interval, preoperative IVC significantly shortened operation time, and reduced intraoperative bleeding and iatrogenic retinal breaks. Long and short intervals reduced endodiathermy application, and mid and short intervals reduced postoperative vitreous hemorrhage. Moreover, long and mid intervals improved BCVA and central macular thickness. However, very long interval was associated with an increased risk of postoperative vitreous hemorrhage (RR: 3.27, 95%CI: 1.84 to 5.83). Moreover, mid interval was better than intraoperative IVC in shortening operation time (MD: -19.74, 95%CI: -33.31 to -6.17). ConclusionsThere are no discernible effects of intraoperative IVC on PDR, but preoperative IVC, except for very long interval, is an effective adjuvant to PPV for treating PDR.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials
    Chen, G. H.
    Tzekov, R.
    Mao, S. H.
    Tong, Y. H.
    Jiang, F. Z.
    Li, W. S.
    EYE, 2022, 36 (03) : 619 - 626
  • [2] Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials
    G. H. Chen
    R. Tzekov
    S. H. Mao
    Y. H. Tong
    F. Z. Jiang
    W. S. Li
    Eye, 2022, 36 : 619 - 626
  • [3] Intravitreal conbercept improves outcome in patients undergoing vitrectomy for proliferative diabetic retinopathy: A systematic review and meta-analysis
    Pranata, Raymond
    Vania, Amelinda
    JOURNAL OF EVIDENCE BASED MEDICINE, 2020, 13 (02) : 116 - 124
  • [4] Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy
    Gao, Shuang
    Lin, Zhongjing
    Chen, Yanwei
    Xu, Jianmin
    Zhang, Qiong
    Chen, Jili
    Shen, Xi
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (05) : 304 - 310
  • [5] Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
    Mao, Jian-Bo
    Wu, Han-Fei
    Chen, Yi-Qi
    Zhao, Shi-Xin
    Tao, Ji-Wei
    Zhang, Yun
    Zheng, Bin
    Wang, Lin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1217 - 1221
  • [6] Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
    Jian-Bo Mao
    Han-Fei Wu
    Yi-Qi Chen
    Shi-Xin Zhao
    Ji-Wei Tao
    Yun Zhang
    Bin Zheng
    Lin Wang
    Li-Jun Shen
    International Journal of Ophthalmology, 2018, (07) : 1217 - 1221
  • [7] Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
    Yang, Zhikun
    Di, Yu
    Ye, Junjie
    Yu, Weihong
    Guo, Zijian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [8] Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy
    Ren, Xinjun
    Bu, Shaochong
    Zhang, Xiaomin
    Jiang, Yuanfeng
    Tan, Liangzhang
    Zhang, Hong
    Li, Xiaorong
    EYE, 2019, 33 (07) : 1177 - 1183
  • [9] Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy
    Xinjun Ren
    Shaochong Bu
    Xiaomin Zhang
    Yuanfeng Jiang
    Liangzhang Tan
    Hong Zhang
    Xiaorong Li
    Eye, 2019, 33 : 1177 - 1183
  • [10] Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
    Xu, Wei
    Cheng, Weijing
    Yao, Yao
    Guo, Jian
    Xu, Guoxing
    JOURNAL OF OPHTHALMOLOGY, 2019, 2019